Kulwara Meksawan1, Chorsakon Chaotrakul2, Napat Leeaphorn3, Suthep Gonlchanvit4, Somchai Eiam-Ong5, Talerngsak Kanjanabuch6. 1. Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand Cell-based Drug and Health Product Development Research Unit, Chulalongkorn University, Bangkok, Thailand. 2. Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. 3. Department of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, New York, USA. 4. Gastrointestinal Motility Research Unit, Division of Gastroenterology. 5. Division of Nephrology, Department of Medicine. 6. Division of Nephrology, Department of Medicine Kidney and Metabolic Disorders Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand golfnephro@hotmail.com.
Abstract
UNLABELLED: ♦ BACKGROUND: Fructo-oligosaccharides (FOS) exhibit soluble-fiber properties that beneficially affect bowel function and relieve constipation. The effects of FOS supplementation on constipation and biochemical parameters were examined in elderly continuous ambulatory peritoneal dialysis (CAPD) patients. ♦ METHODS: This randomized, double-blind, placebo-controlled, cross-over study was performed in elderly CAPD patients (5 males and 4 females) with chronic constipation. All subjects were randomly assigned to receive either 20 g FOS or placebo daily for 30 days. After a 14-day washout period, the patients were switched to the other substance for 1 more month. Before and after each treatment period, frequency of defecation, characteristics of feces, and colonic transit were evaluated. Biochemical parameters were also assessed. ♦ RESULTS: Fructo-oligosaccharides significantly increased the frequency of defecation (10.5 ± 2.0 vs 6.2 ± 1.4 times per week, p < 0.005) and changed the feces' appearance from type 1 (nut-like) to type 4 (sausage-like). The colonic transit determined by geometric center (GC) was augmented after FOS supplementation (3.9 ± 0.3 vs 3.2 ± 0.4, p < 0.05). Fructo-oligosaccharides had no effects on biochemical parameters. Fructo-oligosaccharides caused mild discomforts which were well tolerated after dose adjustment. ♦ CONCLUSIONS:Fructo-oligosaccharide supplementation is effective, well tolerated, and can be an alternative to other laxatives in CAPD patients with constipation. Further studies are needed to better assess the biochemical effects of FOS in the chronic kidney disease population.
RCT Entities:
UNLABELLED: ♦ BACKGROUND:Fructo-oligosaccharides (FOS) exhibit soluble-fiber properties that beneficially affect bowel function and relieve constipation. The effects of FOS supplementation on constipation and biochemical parameters were examined in elderly continuous ambulatory peritoneal dialysis (CAPD) patients. ♦ METHODS: This randomized, double-blind, placebo-controlled, cross-over study was performed in elderly CAPD patients (5 males and 4 females) with chronic constipation. All subjects were randomly assigned to receive either 20 g FOS or placebo daily for 30 days. After a 14-day washout period, the patients were switched to the other substance for 1 more month. Before and after each treatment period, frequency of defecation, characteristics of feces, and colonic transit were evaluated. Biochemical parameters were also assessed. ♦ RESULTS:Fructo-oligosaccharides significantly increased the frequency of defecation (10.5 ± 2.0 vs 6.2 ± 1.4 times per week, p < 0.005) and changed the feces' appearance from type 1 (nut-like) to type 4 (sausage-like). The colonic transit determined by geometric center (GC) was augmented after FOS supplementation (3.9 ± 0.3 vs 3.2 ± 0.4, p < 0.05). Fructo-oligosaccharides had no effects on biochemical parameters. Fructo-oligosaccharides caused mild discomforts which were well tolerated after dose adjustment. ♦ CONCLUSIONS:Fructo-oligosaccharide supplementation is effective, well tolerated, and can be an alternative to other laxatives in CAPD patients with constipation. Further studies are needed to better assess the biochemical effects of FOS in the chronic kidney disease population.
Authors: A Attar; M Lémann; A Ferguson; M Halphen; M C Boutron; B Flourié; E Alix; M Salmeron; F Guillemot; S Chaussade; A M Ménard; J Moreau; G Naudin; M Barthet Journal: Gut Date: 1999-02 Impact factor: 23.059
Authors: C Coudray; J Bellanger; C Castiglia-Delavaud; C Rémésy; M Vermorel; Y Rayssignuier Journal: Eur J Clin Nutr Date: 1997-06 Impact factor: 4.016
Authors: Ayman H Abd El-Aziz; Mahmoud M Abo Ghanima; Walaa F Alsanie; Ahmed Gaber; Abd El-Wahab Alsenosy; Ahmed A Easa; Sherif A Moawed; Sayed Haidar Abbas Raza; Ahmed Elfadadny; Hany Abo Yossef; Wafaa M Ghoneem; Mustafa Shukry; Amin Omar Hendawy; Khalid Mahrose Journal: Animals (Basel) Date: 2022-06-13 Impact factor: 3.231
Authors: Paula Perez-Pardo; Esther M de Jong; Laus M Broersen; Nick van Wijk; Amos Attali; Johan Garssen; Aletta D Kraneveld Journal: Front Aging Neurosci Date: 2017-03-20 Impact factor: 5.750
Authors: Paula Perez-Pardo; Laus M Broersen; Tessa Kliest; Nick van Wijk; Amos Attali; Johan Garssen; Aletta D Kraneveld Journal: Front Aging Neurosci Date: 2018-08-03 Impact factor: 5.750
Authors: Guobin Su; Xindong Qin; Changyuan Yang; Alice Sabatino; Jaimon T Kelly; Carla Maria Avesani; Juan Jesus Carrero Journal: Clin Kidney J Date: 2021-09-14